Jason Sprowl, PhD, assistant professor, Department of Pharmaceutical Sciences, has been awarded a $432,182 grant from National Institute on Deafness and Other Communication Disorders (NIDCD) and the National Institutes of Health (NIH). The study, called “Role of MCT6 in mediating cisplatin-induced ototoxicity,” will help researchers understand and prevent a prevalent type of drug-induced hearing loss in cancer patients.